RxSight Inc (RXST)
58.47
-1.05
(-1.76%)
USD |
NASDAQ |
May 31, 16:00
58.35
-0.12
(-0.21%)
Pre-Market: 20:00
RxSight SG&A Expense (Annual): 74.80M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 74.80M |
December 31, 2022 | 58.66M |
December 31, 2021 | 32.80M |
Date | Value |
---|---|
December 31, 2020 | 15.18M |
December 31, 2019 | 15.20M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
15.18M
Minimum
2020
74.80M
Maximum
2023
39.33M
Average
32.80M
Median
2021
SG&A Expense (Annual) Benchmarks
Alphatec Holdings Inc | 374.08M |
Masimo Corp | 664.00M |
Tactile Systems Technology Inc | 169.19M |
iRhythm Technologies Inc | 385.64M |
Shockwave Medical Inc | 330.10M |